Cargando…
Rosiglitazone as an option for patients with acromegaly: a case series
INTRODUCTION: In the patient with acromegaly, pituitary surgery is the therapeutic standard. Despite undergoing surgery, a significant number of patients with acromegaly continue to have uncontrolled growth hormone secretion. These patients require other treatments such as external irradiation and/o...
Autores principales: | Tamez-Pérez, Héctor E, Bahena-García, Ana, Gómez de Ossio, María D, Gutiérrez-Hermosillo, Hugo, Tamez-Peña, Alejandra L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115888/ https://www.ncbi.nlm.nih.gov/pubmed/21600024 http://dx.doi.org/10.1186/1752-1947-5-200 |
Ejemplares similares
-
SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study
por: Tamez-Perez, Héctor Eloy, et al.
Publicado: (2017) -
Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver
por: Zhang, Yichao, et al.
Publicado: (2021) -
Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015) -
El ABC de la medicina científica
por: Tamez Pérez, Héctor Eloy
Publicado: (2012) -
Acromegaly and papillary thyroid carcinoma: A case series
por: Heidarpour, Maryam, et al.
Publicado: (2019)